SUNC Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds LXFR Q1 2026 Earnings EPS Surges Past Estimates with 32 Beat Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management Capital Southwest Corporation Q1 2026 Earnings EPS Misses Estimates Stock Slips API Q4 2025 Earnings Positive EPS Surprise Amid Limited Revenue Disclosure OLMA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues